National Trends Reveal Hypertension as the Dominant Driver of Cardiovascular Readmissions
DOI:
https://doi.org/10.5195/ijms.2025.3605Keywords:
Heart Failure, Hospital Readmission, Hypertension, Cardiovascular Diseases, Health Services ResearchAbstract
Introduction: Cardiovascular (CV) hospital readmissions significantly burden the U.S. healthcare system, particularly among patients with heart failure. While previous studies have evaluated all-cause readmission, there is limited understanding of the specific CV diagnoses responsible for short- and long-term hospital returns. This study aimed to identify the leading CV-specific diagnoses contributing to 30-day and 1-year readmissions following an index hospitalization for heart failure to inform targeted interventions and reduce repeat hospitalizations.
Methods: We conducted a retrospective cohort analysis using the Nationwide Readmissions Database (NRD) from 2016 to 2022. A total of 31,886,859 weighted hospitalizations were included. Adult patients (≥18 years) admitted with a primary diagnosis of heart failure were included. The primary outcome was CV-specific readmission within 30 days and 1 year, based on ICD-10 codes for heart failure/pulmonary edema, hypertension and hypertensive crisis, myocardial infarction, arrhythmias/conduction disorders, stroke, pulmonary circulation disorders, and venous thromboembolism. Survey-weighted descriptive statistics, stratified by 30-day and 1-year CV-specific readmission status, identified leading diagnoses. Adjusted models accounted for demographics, comorbidity burden (Charlson Comorbidity Index), and hospital characteristics. Chi-square tests and phi-coefficients (φ) quantified associations, with statistical significance set at p < 0.001.
Results: Among patients initially hospitalized for heart failure, hypertension or hypertensive crisis accounted for the majority of CV-specific readmissions at both 30 days (64.8%) and 1 year (65.1%). Recurrent heart failure or pulmonary edema was the second most common cause, followed by arrhythmias, acute myocardial infarction, and stroke. All comparisons versus hypertension or hypertensive crisis were statistically significant (p < 0.001; φ = 0.53–0.69). These diagnostic patterns remained consistent over time.
Conclusion: Hypertension-related complications and recurrent decompensated heart failure are the predominant causes of early and late CV-specific readmissions. These findings emphasize the need for robust post-discharge blood pressure control and longitudinal heart failure management. By identifying high-yield targets for intervention, this study supports the development of more effective care models aimed at reducing the CV readmission burden in this vulnerable population.
Table 1. Thirty-Day and One-Year Readmission Rates Across Cardiovascular Conditions Compared with Hypertension
N = 31,886,859
30-Day Readmission
% (N)
SE
χ²(1) vs. HTN
p-values vs. HTN
φ-coefficient vs. HTN
Acute Myocardial Infarction
5.90 (1,881,325)
0.024
24,202,174
< 0.001
0.62
Arrhythmias / Conduction
9.24 (2,946,346)
0.030
21,108,975
< 0.001
0.58
Heart Failure / Pulmonary Edema
12.90 (4,113,504)
0.035
18,076,867
< 0.001
0.53
Hypertension / Hypertensive Crisis (HTN)
64.80 (20,662,685)
0.049
Pulmonary Circulation
0.62 (197,699)
0.008
29,836,652
< 0.001
0.68
Stroke / Transient Ischemic Attack
5.61 (1,788,853)
0.024
24,486,831
< 0.001
0.62
Venous Thromboembolism
0.84 (267,850)
0.009
29,581,492
< 0.001
0.68
1-Year Readmission
Acute Myocardial Infarction
6.37 (2,031,193)
0.017
23,946,025
< 0.001
0.61
Arrhythmias / Conduction
8.79 (2,802,855)
0.020
21,700,892
< 0.001
0.58
Heart Failure / Pulmonary Edema
12.10 (3,858,310)
0.023
18,896,344
< 0.001
0.54
Hypertension / Hypertensive Crisis
65.10 (20,758,345)
0.034
Pulmonary Circulation
0.61 (194,510)
0.006
30,057,395
< 0.001
0.69
Stroke / Transient Ischemic Attack
6.14 (1,957,853)
0.017
24,168,617
< 0.001
0.62
Venous Thromboembolism
0.79 (251,906)
0.006
29,848,196
< 0.001
0.68
References
Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–619. doi:10.1161/HHF.0b013e318291329a
Dunlay SM, Weston SA, Jacobsen SJ, et al. Risk factors for heart failure: a population-based case-control study. Am J Med. 2009;122:1023–1028. doi:10.1016/j.amjmed.2009.04.022
Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–1562. doi:10.1001/jama.1996.03530440037034
Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068–3072. doi:10.1161/01.CIR.0000039105.49749.6F
Lasica R, Djukanovic L, Vukmirovic J, et al. Clinical review of hypertensive acute heart failure. Medicina. 2024;60:133. doi:10.3390/medicina60010133
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Kyle E. Thurmann, MS, Trisha G. Mukherjee, Joseph G. Dantin, MS, JD, Paul T. Kang, PhD, Michael D. White, MD

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org


